Ken Griffin Exscientia PLC Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Exscientia PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 1,200 shares of EXAI stock, worth $6,240. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,200
Previous 19,000
93.68%
Holding current value
$6,240
Previous $108,000
94.44%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EXAI
# of Institutions
83Shares Held
34.9MCall Options Held
22.8KPut Options Held
178K-
Softbank Group Corp Minato Ku Tokyo, M05.68MShares$29.5 Million0.15% of portfolio
-
Sb Global Advisers LTD London, X05.68MShares$29.5 Million3.51% of portfolio
-
Laurion Capital Management LP New York, NY5.14MShares$26.7 Million0.31% of portfolio
-
Baillie Gifford & CO4.4MShares$22.9 Million0.02% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C31.93MShares$10 Million0.4% of portfolio
About Exscientia plc
- Ticker EXAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,461,000
- Market Cap $637M
- Description
- Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...